Related Experiment Video
Updated: Jul 5, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Thyroglossal duct cyst carcinoma with concurrent thyroid carcinoma: a case report
Vittorio Gebbia1, Carlo Di Gregorio, Marco Attard
1Department of Experimental Oncology and Clinical Applications, University of Palermo, Italy. vittorio.gebbia@tin.it
Journal of Medical Case Reports
|May 1, 2008
Summary
Thyroglossal duct carcinoma, a rare neck mass, requires careful diagnosis. Surgical management, including Sistrunk
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Endocrinology
Background:
- Thyroglossal duct carcinoma presents as a rare midline neck mass, often mimicking benign cysts.
- Differential diagnosis relies on pathological examination, with cytology, ultrasound, and CT aiding malignancy assessment.
Purpose of the Study:
- To present a case of thyroglossal duct carcinoma with concurrent thyroid carcinoma and lymph node metastases.
- To discuss the diagnostic and management strategies for this rare condition.
Main Methods:
- Case report of a 40-year-old woman with thyroglossal duct carcinoma and concurrent thyroid carcinoma.
- Review of diagnostic modalities including cytology, ultrasound, and CT.
- Discussion of surgical and adjuvant treatment options.
Main Results:
- The case involved a 40-year-old woman with thyroglossal duct carcinoma and concurrent thyroid carcinoma with locoregional lymph node metastases.
- Follow-up extended over 4 years.
Conclusions:
- Sistrunk's surgery is the primary treatment for thyroglossal duct anomalies.
- Thyroidectomy, lymph node dissection, and radioactive iodine therapy may be necessary for carcinoma.
- Pre-operative evaluation is crucial for surgical planning.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...